http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115176999-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e1cc6088514e768f29aa583b4c4eadc |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23P10-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23P10-30 |
| filingDate | 2022-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4dac7ac38cdce6120770da70b37933f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09c1b0b44bfe1ea6790dbf6f4f3e972f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_292b59ef629f2904ae2cd2b4b7af50e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50aae226c853c6f70c288355941c28a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5e23ebc92472061a0972608a427f386 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5c7791c30f643e6ddd95e1a77263065 |
| publicationDate | 2022-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-115176999-A |
| titleOfInvention | Antioxidant composition with stable activity and preparation method thereof |
| abstract | The invention discloses an active and stable antioxidant composition and a preparation method thereof, belonging to the technical field of functional health care products. Sugar, sodium carboxymethyl cellulose and magnesium stearate are used as core raw materials, combined with other auxiliary materials, and there are three preparation steps in total. The NMN, resveratrol, ellagic acid, β-gluco-oligosaccharide and trehalose in the present invention can effectively inhibit the activity of tyrosinase, reduce the content of total cholesterol, reduce the content of uric acid and neutral fat, and improve the total metabolism , effectively improve the problem of neurasthenia. In addition to functional health care effects, this ratio can effectively alleviate the instability of NMN's own properties, and it is easily decomposed into nicotinamide after being heated and damp. There are no restrictions on the storage conditions of the capsules, and the high retention rate and high activity of NMN are maintained during transportation and storage to ensure that the drug can fully exert its curative effect while reducing side reactions. |
| priorityDate | 2022-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.